Sequence Dependent Radiosensitization of EGFR Mutant Non-small Cell Lung Cancer by Gefitinib Is Mediated by Senescence

被引：0
|
作者：
Huber, K. E. [1 ]
Iyer, V. [1 ]
Huber, W. E. [1 ]
Wazer, D. E. [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [1] Sequence Dependent Radiosensitization of EGFR Mutant NSCLC by Gefitinib is Mediated by Senescence
    Huber, K. E.
    Iyer, V.
    Huber, W. E.
    Wazer, D. E.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S249 - S249
  • [2] Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib
    Naito, Yoichi
    Goto, Koichi
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1027 - 1040
  • [3] For EGFR Mutant Non-Small Cell Lung Cancer, Treatment Sequence Matters?
    An, Ho Jung
    Shin, Yuneyoung
    Hong, Sook Hee
    Kim, Young Kyoon
    Kim, Seung Joon
    Lee, Kyo-Young
    Kang, Jin Hyoung
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S436 - S437
  • [4] Gefitinib first or gefitinib second -: Is timing everything in the treatment of EGFR mutant non-small cell lung cancer?
    Jaenne, Pasi A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (08) : 783 - 785
  • [5] Efficacy of gefitinib at reduced dose in EGFR mutant non-small cell lung carcinoma
    Kwok, Wang Chun
    Ho, James Chung Man
    Tam, Terence Chi Chun
    Lui, Macy Mei Sze
    Ip, Mary Sau Man
    Lam, David Chi Leung
    ANTI-CANCER DRUGS, 2019, 30 (10) : 1048 - 1051
  • [6] Gefitinib Plus Bevacizumab vs. Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Mori, Masahide
    Ichiki, Masao
    Sukoh, Noriaki
    Kada, Akiko
    Saito, Akiko M.
    Ichinose, Yukito
    IN VIVO, 2019, 33 (02): : 477 - 482
  • [7] Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation
    Hotta, Katsuyuki
    Tabata, Masahiro
    Kiura, Katsuyuki
    Kozuki, Toshiyuki
    Hisamoto, Akiko
    Katayama, Hideki
    Takigawa, Nagio
    Fujimoto, Nobukazu
    Fujiwara, Keiichi
    Ueoka, Hiroshi
    Tanimoto, Mitsune
    ONCOLOGY REPORTS, 2007, 17 (02) : 313 - 317
  • [8] RADIOSENSITIZATION OF NON-SMALL CELL LUNG CARCINOMA BY EGFR INHIBITION
    Keta, Otilija D.
    Bulat, Tanja M.
    Koricanac, Lela B.
    Zakula, Jelena J.
    Cuttone, Giacomo
    Privitera, Giuseppe
    Petrovic, Ivan M.
    Ristic-Fira, Aleksandra M.
    NUCLEAR TECHNOLOGY & RADIATION PROTECTION, 2014, 29 (03): : 233 - 241
  • [9] Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
    Kim, Youjin
    Lee, Se-Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 502 - 509
  • [10] Gefitinib in non-small cell lung cancer
    Tamura, K
    Fukuoka, M
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 985 - 993
12345